Expanding access to cell and gene therapies with McKesson’s Joe DePinto
About this episode
Joe DePinto discusses the current state of cell and gene therapy and advancements to improve patient access.
Joe DePinto, McKesson’s head of cell and gene advanced therapies, supports patients, providers and payers throughout the treatment journey. He’s particularly passionate about helping patients get access to groundbreaking therapeutic interventions. Maria Whitman gets his perspective on the current state of cell and gene therapy and the promising advancements that can ensure more patients receive these treatments. Highlights include: Why strategic partnerships and digital information are...
People in this episode
Host: Maria Whitman
Guest: Joe DePinto
Topics covered
- cell therapy
- gene therapy
- patient access
- healthcare partnerships
- therapeutic interventions
Mentioned in this episode
Organizations: McKesson
More episodes of Transforming Biopharma
- ‘Everything changes at the same time’: On conversational AI with Veeva’s Arno Sosna
- Cultivating resilience: Building a better supply chain with McKesson’s Ammie McAsey
- ‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases
- ‘The hinge moment’: Envisioning transformation with Amgen’s Alex Koehler
- ‘We’re all tech leaders now’: A conversation with Salesforce’s Kyrsten Musich
- How CRM can help pharma break barriers and transform customer engagement
Explore listener stats, chart rankings, contacts and more on the Transforming Biopharma podcast page.